The Joint Qualified Person Symposium is themed “The QP in a new world”. It is the 15th Symposium to be held by the Royal Pharmaceutical Society, Royal Society of Biology and Royal Society of Chemistry.
As a QP, I’m looking forward to attending the upcoming QP Symposium in May 2017. I attended the last symposium in 2015 and I found it a great day for networking with so many QP colleagues and to find out that we all share a lot of common issues and hear how these issues had been dealt with.
This year, I’m particularly looking forward to the sessions run by the MHRA on Annex 16 and serialisation. I’m hoping that we shall hear some real life examples as to the issues the MHRA are seeing with implementation of this recently updated annex.
As the industry gears up for serialisation, it will be particularly interesting to hear about checking packs into databases and what expectations there will be on the QP to verify the data has been properly uploaded.
I am also very interested in the MHRA enforcement group talk. As QPs, we have a great deal of interaction with the inspectorate but very little interaction with the enforcement group. As a pharmacist, I see this as important work. It will be interesting to find out what they do, how it’s done and as QPs, how we may be able to help in the fight to crack down on the illegal trade in pharmaceuticals that have the potential harm to our patients.
Finally, as a speaker at the symposium, I hope you will learn something from my presentation on Transitioning from Traditional Dosage Forms to Advanced Therapeutic Medicinal Products. When I first started working on these products, they were very much seen as the future of treating disease and illness but there were not that many products in research and development and there was little regulatory framework in place. Now we have a regulatory framework and there are quite a few ATMPs showing great promise in the clinic, and there are some products on the market. However, as a practicing QP there is still very little training out there for a QP who wants to transition to these products. The aim of my talk is to show you how I made the transition from releasing traditional dosage forms to ATMPs and hopefully encourage some QPs to embark on a similar journey.
I look forward to meeting you at the symposium.
Robert Smith BSc (Hons), MSc, PgDip, MRPharmS
Director, Smiro Qualitas Ltd
The Joint QP Symposium will be held on 17 May 2017 at Mary Ward House, London WC1. View a full programme of speakers and book online here.